This study tests a new vaccine called H107e/CAF®10b to prevent tuberculosis (TB). It is the first time this vaccine is given to people. The trial involves 140 healthy adults aged 18 to 45 and checks for side effects and how well the vaccine triggers the immune system. The goal is…
Phase: PHASE1 • Sponsor: Statens Serum Institut • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 11:00 UTC